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TECHNOLOGY TRANSFER ?????s 
1. WHAT'S THE TECHNOLOGY & 
COMMERCIAL VALUE? 
2. WHY IS A DEMONSTRATION 
NEEDED? 
3. HOW DID WE GET SEVEN 
PARTIES TO WORK TOGETHER? 
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Hardware, Techniques, and Processes 
115 Portable VidedDigitaf Retinal Fundus 
115 Ultrasonic Device Monitors Fulln 
An inexpensive instrument can be operated with minimal training, under hospital or field conditions. 
Lyndon B. Johnson Space Center, Houston, Texas 
A lightweight, relatively inexpens'w elec- 
tronic and photographic instrument has 
been developed for the detection, monitor- 
ing, and objective quantification of ocular1 
systemic disease or physiological altera- 
tions of the retina, blood vessels, or other 
structures in the anterior and posterior 
chambers of the eye. The instrument can 
be operated with little training. It can func- 
tion with a human or animal subiect seat- 
ed, recumbent. inverted, or in almost any 
other orientation; and in a hospital, lab- 
oratory, field, or other environment. The in- 
strument produces video images that can 
be viewed directly andlor digitized for si- 
multaneous or subsequent analysis. lt can 
also be equipped to produce photographs 
andlor fitted with adaptors to produce ster- 
eoscopic or magnified images of the skin, 
nose, ear, throat, or mouth to detect lesions 
or diseases. 
The instrument is an assembly of com- 
mercially available equipment, some of 
which has been modified slightly to make 
it compatible with the other equipment and 
the overall design. One major component 
is a portable fundus camera with lenses, 
filters, and prisms as required for various 
viewing configurations. The image pro- 
duced by the fundus camera is either 
recorded on 35-mm film or sensed by a 
low-light-level charge-coupled-device 
(0) video camera (see figure) The other 
major components are an electronic view- 
finder, a video monitor for viewing in real 
time, and a computer that digitizes the 
video image. 
Equipment to stabilize the subject's 
head is included, but the instrument can 
be operated without such stabilization The 
operator can adjust the focus on the fun- 
dus camera while viewing through an eye 
piece. using either the 35-mm-filmcamera 
attachment or looking directly at :he eiec- 
The Portable Fundu- 
scope has a modular de- 
sign. Theextension hous- 
ing, video camera, and 
electronic viewfinder can 
be removed and replaced 
with a 35-mm film cam- 
era. The fundus camera 
can be equipped with a 
variety of lenses, prisms, 
and the like. 
tronic viewfinder mounted on the CCD 
camera When the desired image is ob- 
tained, the camera is secured in place. Ex- 
citation and barrier filters can be inserted 
into the fundus camera for fluorescein 
angiography. The images from the CCD 
camera can be directly digitized by the 
computer for storage or transferred via 
telephone lines, computer networks, or 
satellite to remote locations 
By providing for the digital analysis of 
images, the instrument helps physicians 
to compare sequential images from a 
given patient to detect subtle disease pro 
gressions earlier. In addition, the acquisi- 
tion of images as digital information fa- 
cilitates storage, transfer, and manipulation 
to enhance features of interest It also en- 
ables extensive analyses of images. in- 
cluding quantitative analyses of the diam- 
eters of blood vessels and the detection 
and monitoring of changes in retinas 
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caused by hypertension, diabetes, athero- 
sclerosis. vasculitis, uveitis, macular de- 
generation, glaucoma, and infections. The 
instrument can be upgraded easily as ad- 
vanced sources of light, optical equipment, 
CCD cameras, computers, and image- 
analyzing computer programs become 
available. 
This work was done by Gerald R. Taylor 
of Johnson Space Center; Richard 
Meehan of the University of Colorado; and 
No& Hunter, Michael Caputo, and C. 
Robert Gibson of Krug International. For 
further information, Circle 37 on the TSP 
Reguest Card. 
This invention is owned by NASA, and 
a patent application has been filed. In- 
quiries concerning nonexclusive or ex- 
clusive license for its commercial develop 
ment should be addressed to the Patent 
Counsel, Johnson Space Center [see page 
761. Refer to MSC-21675. 
1. WHAT'S THE TECHNOLOGY & 
COMMERCIAL VALUE? 
Funduscope Aids Detection of Disease or 
Physiological Alteration of the Retina, Blood 
Vessels or Other Structures of the Eye as well 
as the Skin, Nose, Ear, Throat, and Mouth 
Remote Diagnosis Allows More Specialists to 
Participate Resulting in: 
-Faster and More Complete Diagnosis 
-Fewer Rescheduled Visits 
-Access to Specialists Otherwise Not 
-1mpmved Health Cam Delivery 
Available 
Remote Consultations will Reduce Physician 
Overhead Costs and Travel Time by 
$132,000,000 Per Year (A.D. Little, 1992) 
Continuing Medical Education Faster, More 
Effectively and More Efficiently Saving 
$100,000,000 Annually in Conference and 
Travel Expenses 
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1.  Field Test Portable Funduscope by Health Care 
Providers 
2. Assess SatelliteTelemedicine Cosmenefit of 
Using the Portable Funduscope 
3. Assess Commercial Market Potential of 
Portable Funduscope 
4. Assess CosUBenefit of Health Care Staff 
Continueing Education via Satellite 
Videoconferencing 
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PARTIES TO WOR 
NASA Headqmnters ($35 
Project Funds to Redu 
: Demonstration 
mercial Risk 
0 Johnson Space Center: Protocols and Results 
with NASA Telemedicine Projects 
e KRUG Life Sciences: Funduscope Availability 
& Training ($4,500 in-kind) 
Scott & White Memohi Hospital ($95,000 & 
$400,000 in-kind): Funduscope Evaluation 
for Telemedicine & Health Care Telelearning 
James Rclmsey Technical Imtitute ($36 1,800 
plus $50,000 in-kind) sponsored by the West 
Virginia Dept. of Education and the 
Appalachian Regional Commission: VoTech 
Skills Training 
0 SpaceTech ($85,000 in-kind): Network 
Integration, Operation & Expansion 
0 MCTTC ($40,000 in-kind) : Project 
Management & Funduscope Market 
Assessment for Commercialization 
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10. PROJECT MANAGEMENT 
1 1 .  RIGHTS TO INTELLECTUAL PROPERTY 
12. RIGHTS TO PHYSICAL PROPERTY 
13. RIGHTS TO PUBLICATION 
14. TRANSPONDER TIME ALLOCATION 
15. INSURANCE & LIABILITY 
16. DISPUTES 
17. TERMINATION 
18. NASA PROVISIONS 
19. EXPANSION OF DEMONSTRATION PROJECT 
20. GENERAL PROVISIONS 
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EXPECTED RESULTS 
1994-95: Demo Expansion to Include 
Additional Medical Centers & Technologies 
1995-97: Commercialization of Portable 
Retinal Funduscope by KRUG & 
Distribution Partner 
1996-98: Commercialization of Portable 
Funduscope with Attachments for Ear, 
Nose, Throat, Mouth and Skin 
1995-99: Telemedicine Becomes 
Established Medical Practice 
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